RALPANCIZUMAB

UNII: YB9L51E4MD
Preferred Substance Name: RALPANCIZUMAB

1407495-04-8
IMMUNOGLOBULIN G2, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED PROTEINASE 1) (HUMAN-MUS MUSCULUS MONOCLONAL PF-05335810 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PF-05335810 LIGHT CHAIN, DIMER
PF-05335810
RALPANCIZUMAB [INN]
RALPANCIZUMAB [USAN]
RALPANCIZUMAB [WHO-DD]
RN317
RN-317

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

RALPANCIZUMAB

Synonyms and Mappings

Resources

Note